相关实验视频

Updated: Jun 3, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

阿斯特拉加勒斯膜草通过抑制FLI1瘤基因和增强抗瘤免疫力减轻白血病

Kunlin Yu^1,2, Yao Tang^1,2, Chunlin Wang^1,2

¹State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 561113, China.

International journal of molecular sciences

|January 8, 2025

概括

阿斯特拉加勒斯膜 (AM) 通过抑制FLI1和调节免疫反应,表现出强大的抗白血病特性. 它的化合物,包括阿斯特拉加索酸-A,为抗白血病的新型组合疗法提供了一个有前途的途径.

科学领域:

植物化学植物化学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

阿斯特拉 (Astragalus membranaceus) 是一种用于治疗癌症的传统中医药.
红血球白血病是一种显著的血液性恶性瘤.
了解癌症治疗中自然化合物的分子机制至关重要.

研究的目的:

为了研究阿斯特拉加卢斯 (Astragalus membranaceus) 的抗白血病作用.
为了确定AM中负责抗白血病活性的活性化合物.
阐明参与AM抗白血病作用的分子标和途径.

主要方法:

化学分析和质谱测量用于识别AM中的化合物.
在体外细胞培养和体内红血球白血病的小鼠模型.
分子对接分析以预测化合物-标相互作用.
基因表达分析以评估途径调制.

主要成果:

在小鼠模型中,AM注射显示出显著的抗白血病效应.
贝图林酸,凯姆菲罗尔,海德拉格宁和福莫诺尼丁被确定为针对FLI1.1的关键抑制剂.
通过向IDO1,TDO2和基因组胺脱酶 (HDC),阿斯特拉加索酸A (As-A) 在体内抑制了白血病发生.
As-A抑制了三聚胺介导的Kyn生产和关键的炎症基因.

结论:

AM具有强大的抗白血病活性,由多种化合物和途径介导.
FLI1是AM衍生化合物在白血病抑制中的关键标.
甲酸-A通过HDC调节免疫微环境,呈现出一种新的治疗策略.
对AM成分的进一步研究可能会导致白血病的有效组合疗法.

关键词:

阿斯特拉加勒斯的膜状.DTO2 DTO2是指DTO2是指DTO2DTO2DTO2DTO2DTO2 FLI1 FLI1 的意思是什么?在 HDC HDC 的情况下,标签: 标签: IDO1 标签: IDO1 标签: IDO1 药物蛋白相互作用抑制白血病的抑制作用传统的中国医药传统的中国医药.瘤微环境是一个微环境.

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...